Increased illness experience preceding chronic fatigue syndrome: A case control study

Journal of the Royal College of Physicians of London

Volumn 32, Issue 1, 1998, Pages 44-48

  Hall, G H ^b   Hamilton, W T ^b   Round, A P ^a  

^a Public Health Medicine   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CASE CONTROL STUDY; CHRONIC FATIGUE SYNDROME; COMPARATIVE STUDY; FEMALE; HUMAN; INSURANCE; MALE; MULTIPLE SCLEROSIS; MULTIVARIATE ANALYSIS; RISK; SEX DIFFERENCE; STATISTICAL MODEL;

ADULT; AGE FACTORS; CASE-CONTROL STUDIES; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; LOGISTIC MODELS; MALE; MULTIPLE SCLEROSIS; MULTIVARIATE ANALYSIS; ODDS RATIO; SEX FACTORS;

EID: 0031603041     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Holmes G, Kaplan K, Gantz N, Komaroff AL, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988;108:387-9.
2. Scadding JG. Essentialism and nominalism in medicine: logic of diagnosis in disease terminology. Lancet 1996;348:594-6.
3. Leitch AG. Neurasthenia, myalgic encephalitis or cryptogenic chronic fatigue syndrome? QJ Med 1995;88:447-50.
4. Report of the Joint Working Group of the Royal Colleges of Physicians, Psychiatrists and General Practitioners. Chronic fatigue syndrome. London: RCP, 1996.
5. Yousef G, Bell E, Mann G, et al. Chronic enterovirus infection in patients with postviral fatigue syndrome. Lancet 1988;i:146-50.
6. Bates DW, Buchwald D, Lee J, Kith P, et al. Clinical laboratory test findings in patients with chronic fatigue syndrome. Arch Intern Med 1995;155:97-103.
7. DeLuca J, Johnson SK, Bldowicz D, Natelson BH. Neuropsychological impairments in chronic fatigue syndrome, multiple sclerosis and depression. J Neurol Neurosurg Psychiatry 1995;58:38-43.
8. Taerk G, Gnam W. A psychodynamic view of the chronic fatigue syndrome. The role of object relations in etiology and treatment. Gen Hosp Psychiatry 1994;16:319-25.
9. Dallal GE. LOGISTIC: A logistic regression program for the IBM PC. American Statistician 1988;42:272.
10. Katon W, Russo J. Chronic fatigue syndrome criteria: a critique of the requirements for multiple physical complaints. Arch Int Med 1992;152:1569-70.
11. Clark MR, Katon W, Russo J, Kith P, et al. Chronic fatigue: risk factors for symptom persistence in a 2 year follow-up study. Am J Med 1995;98:187-95.
12. Lewis G, Wessley S. The epidemiology of fatigue; more questions than answers. J Epidemiol Community Health 1992;46:92-7.
13. Tuckett D (ed.). An introduction to medical sociology. London: Tavistock, 1976.
14. Verbrugge L, Asione S. Exploring the iceberg: common symptoms and how people care for them. Med Care 1987;25:539-63.
15. Pendleton P, Schofield T, Tate P, Havelock P. The consultation: an approach to learning and teaching. Oxford: Oxford University Press, 1984.
16. Woodward RV, Broom DH, Legge DG. Diagnosis in chronic illness: disabling or enabling - the case of chronic fatigue syndrome. J R Soc Med 1995;88:325-9.
17. Kermode-Scott B. Don't worry about the label. Diagnose underlying perpetuating factors in chronic fatigue syndrome. Can Family Physician 1995;41:1126-8.
18. Schweitzer R, Robertson DL, Kelly B, Whiting J. Illness behaviour of patients with chronic fatigue syndrome. J Psychosom Res 1994;38:41-9.
19. Trigwell P, Hatcher S, Johnson M, Stanley P, House A. 'Abnormal' illness behaviour in chronic fatigue syndrome and multiple sclerosis. Br Med J 1995;11:15-8.
20. Ware NC. Society, mind and body in chronic fatigue syndrome: an anthropological view. Ciba Found Symp 1993;173:62-73.
21. Abbey SE. Somatization, illness attribution and the sociocultural psychiatry of chronic fatigue syndrome. Ciba Found Symp 1993;173:238-52.
22. Vercoulen JH, Swanink CM, Zitman FG, Vreden SG, et al. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 1996;347:858-61.
23. Steinberg P, McNutt BE, Marshall P, Schenck C, et al. Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome. J Allergy Clin Immunology 1996;97:119-26.
24. Sharpe M, Hawton K, Simkin S, Suraway C, et al. Cognitive behaviour therapy for the chronic fatigue syndrome: a randomised controlled trial. Br Med J 1996;312:22-6.
25. Euga R, Chalder T, Deale A, Wessley S. A comparison of the characteristics of chronic fatigue syndrome in primary and tertiary care. Br J Psychiatry 1996;168:121-6.
26. Lloyd AR, Hickie I, Broughton CR, Spencer O, Wakefield D. Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust, 1990;153:522-8.
27. Wessely S, Chalder T, Hirsch S, Pawlikowska T, et al. Postinfectious fatigue: prospective cohort study in primary care. Lancet 1995;345:1333-8.
28. Fukuda K, Straus SE, Hickie I, Sharp MC, et al. Chronic fatigue syndrome: a comprehensive approach to its definition and management. Ann Intern Med 1994;121:953-9.
29. White PD, Grover SA, Kangro HO, Thomas JM, Amess J, Clare AW. The existence of a fatigue syndrome after glandular fever. Psychol Med 1995;25:907-16.
30. White PD, Grover SA, Kangro HO, Thomas JM, et al. The validity and reliability of the fatigue syndrome that follows glandular fever. Psychol Med 1995;25:917-24.
31. Sharpe MC, Hawton KE, Seagraott V, Pasvol G. Patients who present with fatigue: a follow-up of referrals to an infectious diseases clinic. Br Med J 1992;305:147-52.
32. Wilson A, Hickie I, Lloyd A, Hadzi-Pavlovich D, et al. Longitudinal study of outcome of chronic fatigue syndrome. Br Med J 1994;308:756-9.